25 years is a long time and a nice round number. As such, I will be stepping down as managing director of OCR on June 30th. Through the remainder of the year I will serve as Strategic Advisor for Technology Transfer and Commercialization in the Office of the Provost, an endeavor I am looking forward to.
When I began my journey at Yale those 25 years ago, I couldn’t have imagined how rewarding my time here would be. I’m deeply grateful for the experiences my time at OCR has afforded me: witnessing ideas transform into successful companies, watching scientists become entrepreneurs, and seeing the fruits of our collective labors become tangible impact on human health and well-being has been unexplainably gratifying. As you all know, the process to take a drug from lab discovery to biotech startup to human clinical trials and, ultimately, to market is a long and complex one, and I’m blessed to have seen many of you successfully engage in this arduous cycle during my time at OCR.
The work we do is important, it requires perseverance, and it truly takes a village to accomplish. I will forever be indebted to have been part of that village.
Associate Provost for Research Lisa D’Angelo will step in as interim managing director of OCR until a long-term replacement is selected. Please join me in welcoming her. I know she is in great hands in this thriving community of ours.
To my team at OCR, Yale, and the entire innovation ecosystem: thank you. It’s been a hell of a run!
